ASSURA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.44 GBX | +1.37% |
|
+1.07% | -13.88% |
| Sales 2024 * | 147M 183M 14.68B | Sales 2025 * | 153M 191M 15.27B | Capitalization | 1.24B 1.55B 124B |
|---|---|---|---|---|---|
| Net income 2024 * | -31M -38.72M -3.1B | Net income 2025 * | 196M 245M 19.6B | EV / Sales 2024 * | 16.6 x |
| Net Debt 2024 * | 1.2B 1.5B 120B | Net Debt 2025 * | 1.24B 1.54B 124B | EV / Sales 2025 * | 16.2 x |
| P/E ratio 2024 * |
41.4
x | P/E ratio 2025 * |
9.36
x | Employees | 86 |
| Yield 2024 * |
7.79% | Yield 2025 * |
8.06% | Free-Float | 99.76% |
More Fundamentals
* Assessed data
More news
Latest transcript on Assura Plc
More recommendations
More press releases
| 1 day | +1.37% | ||
| 1 week | +1.07% | ||
| Current month | -2.08% | ||
| 1 month | -0.24% | ||
| 3 months | -7.29% | ||
| 6 months | +5.02% | ||
| Current year | -13.88% |
1 week
40.50
42.22
1 month
39.7443.34
Current year
39.7449.04
1 year
38.3853.00
3 years
38.3880.60
5 years
38.3888.00
10 years
38.3888.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jonathan Murphy
CEO | Chief Executive Officer | 52 | 31/12/12 |
Jayne Cottam
DFI | Director of Finance/CFO | 50 | 03/08/17 |
Joanne Cullen
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Orla Ball
BRD | Director/Board Member | 53 | 31/03/15 |
Jonathan Davies
BRD | Director/Board Member | 62 | 31/05/18 |
Jonathan Murphy
CEO | Chief Executive Officer | 52 | 31/12/12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.16% | 130 M€ | +0.54% | ||
| 0.03% | 773 M€ | -.--% | - | |
| 0.02% | 11 M€ | +5.01% | - | |
| 0.02% | 208 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 41.44 | +1.37% | 22,255,240 |
| 25/04/24 | 40.88 | -0.05% | 6,172,003 |
| 24/04/24 | 40.9 | -2.15% | 6,863,646 |
| 23/04/24 | 41.8 | +0.87% | 29,315,130 |
| 22/04/24 | 41.44 | +1.07% | 4,209,210 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotes
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests and treatments in the community. The Company is a long-term property partner to more than 600 medical centers. The Company owns and manages a portfolio of about 607 properties. Its subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, and others.
Sector
Specialized REITs
Calendar
15/05/2024
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
0.4144
GBP
Average target price
0.507
GBP
Spread / Average Target
+22.35%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.88% | 1.54B | |
| +4.62% | 55.76B | |
| -11.72% | 17.72B | |
| -5.05% | 13.23B | |
| +1.40% | 7.68B | |
| -16.54% | 5.39B | |
| +8.62% | 3.28B | |
| -2.31% | 3.23B | |
| -5.42% | 3.06B | |
| -8.15% | 2.73B |
- Stock Market
- Equities
- AGR Stock
